Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I.
Human serum albumin (HSA) is an abundant transport protein found in plasma that binds a wide variety of drugs in two primary binding sites (I and II) and can have a significant impact on their pharmacokinetics. We have determined the crystal structures at 2.5 A-resolution of HSA-myristate complexed with the R-(+) and S-(-) enantiomers of warfarin, a widely used anticoagulant that binds to the protein with high affinity. The structures confirm that warfarin binds to drug site I (in subdomain IIA) in the presence of fatty acids and reveal the molecular details of the protein-drug interaction. The two enantiomers of warfarin adopt very similar conformations when bound to the protein and make many of the same specific contacts with amino acid side chains at the binding site, thus accounting for the relative lack of stereospecificity of the HSA-warfarin interaction. The conformation of the warfarin binding pocket is significantly altered upon binding of fatty acids, and this can explain the observed enhancement of warfarin binding to HSA at low levels of fatty acid.
Petitpas
I
I
Biophysics Section, Blackett Laboratory, Imperial College of Science, Technology, and Medicine, London SW7 2BW, United Kingdom.
Bhattacharya
A A
AA
Twine
S
S
East
M
M
Curry
S
S
D000418:Albumins / Q000737:chemistry / Q000378:metabolism*; D001665:Binding Sites; D018360:Crystallography, X-Ray; D006801:Humans; D008958:Models, Molecular; D019814:Myristic Acid / Q000737:chemistry; D011485:Protein Binding; D011487:Protein Conformation; D013237:Stereoisomerism; D014859:Warfarin / Q000737:chemistry / Q000378:metabolism*
D000418:Albumins; D019814:Myristic Acid; D014859:Warfarin